Pharmagest Interactive SA
F:PHF
Balance Sheet
Balance Sheet Decomposition
Pharmagest Interactive SA
Current Assets | 132.3m |
Cash & Short-Term Investments | 54.7m |
Receivables | 67.3m |
Other Current Assets | 10.3m |
Non-Current Assets | 261.8m |
Long-Term Investments | 95.1m |
PP&E | 32.9m |
Intangibles | 130.3m |
Other Non-Current Assets | 3.5m |
Current Liabilities | 108.1m |
Accounts Payable | 16.1m |
Other Current Liabilities | 92m |
Non-Current Liabilities | 66.6m |
Long-Term Debt | 44.7m |
Other Non-Current Liabilities | 22m |
Balance Sheet
Pharmagest Interactive SA
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
13
|
10
|
14
|
21
|
26
|
21
|
34
|
35
|
23
|
18
|
|
Cash |
5
|
4
|
6
|
11
|
18
|
10
|
27
|
23
|
23
|
18
|
|
Cash Equivalents |
7
|
6
|
9
|
10
|
7
|
12
|
7
|
12
|
0
|
0
|
|
Short-Term Investments |
35
|
41
|
28
|
28
|
29
|
29
|
30
|
30
|
45
|
36
|
|
Total Receivables |
19
|
20
|
26
|
32
|
40
|
43
|
41
|
49
|
60
|
67
|
|
Accounts Receivables |
15
|
16
|
20
|
23
|
32
|
35
|
32
|
37
|
47
|
53
|
|
Other Receivables |
3
|
4
|
6
|
9
|
8
|
8
|
9
|
11
|
13
|
14
|
|
Inventory |
2
|
2
|
3
|
3
|
5
|
4
|
7
|
9
|
9
|
10
|
|
Other Current Assets |
0
|
4
|
13
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
69
|
78
|
84
|
90
|
107
|
98
|
111
|
122
|
137
|
132
|
|
PP&E Net |
4
|
5
|
6
|
6
|
9
|
20
|
28
|
28
|
27
|
33
|
|
PP&E Gross |
4
|
5
|
6
|
6
|
9
|
20
|
28
|
28
|
27
|
33
|
|
Accumulated Depreciation |
7
|
8
|
9
|
10
|
13
|
16
|
21
|
27
|
32
|
34
|
|
Intangible Assets |
11
|
12
|
14
|
19
|
24
|
30
|
37
|
40
|
39
|
40
|
|
Goodwill |
28
|
28
|
31
|
39
|
46
|
50
|
66
|
84
|
83
|
90
|
|
Long-Term Investments |
1
|
1
|
16
|
20
|
36
|
59
|
53
|
55
|
63
|
95
|
|
Other Long-Term Assets |
1
|
0
|
0
|
4
|
3
|
3
|
2
|
2
|
3
|
4
|
|
Other Assets |
28
|
28
|
31
|
39
|
46
|
50
|
66
|
84
|
83
|
90
|
|
Total Assets |
114
N/A
|
124
+9%
|
151
+22%
|
178
+18%
|
224
+26%
|
258
+15%
|
296
+15%
|
330
+12%
|
351
+6%
|
394
+12%
|
|
Liabilities | |||||||||||
Accounts Payable |
6
|
7
|
8
|
10
|
12
|
13
|
14
|
16
|
17
|
16
|
|
Short-Term Debt |
0
|
0
|
6
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
1
|
3
|
5
|
10
|
17
|
17
|
18
|
22
|
|
Other Current Liabilities |
22
|
20
|
24
|
40
|
47
|
49
|
50
|
61
|
63
|
70
|
|
Total Current Liabilities |
28
|
27
|
39
|
52
|
65
|
72
|
81
|
94
|
98
|
108
|
|
Long-Term Debt |
1
|
1
|
3
|
14
|
37
|
37
|
55
|
57
|
46
|
45
|
|
Deferred Income Tax |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Minority Interest |
0
|
1
|
2
|
2
|
3
|
4
|
6
|
6
|
7
|
8
|
|
Other Liabilities |
2
|
4
|
4
|
6
|
5
|
17
|
10
|
12
|
8
|
12
|
|
Total Liabilities |
32
N/A
|
33
+3%
|
49
+46%
|
76
+55%
|
110
+45%
|
131
+19%
|
153
+17%
|
171
+12%
|
161
-6%
|
175
+9%
|
|
Equity | |||||||||||
Common Stock |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
Retained Earnings |
78
|
88
|
99
|
99
|
111
|
125
|
140
|
156
|
187
|
216
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
81
N/A
|
91
+12%
|
102
+12%
|
103
+0%
|
114
+11%
|
128
+12%
|
143
+12%
|
159
+11%
|
190
+19%
|
219
+16%
|
|
Total Liabilities & Equity |
114
N/A
|
124
+9%
|
151
+22%
|
178
+18%
|
224
+26%
|
258
+15%
|
296
+15%
|
330
+12%
|
351
+6%
|
394
+12%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|